Targeted Radionuclide Therapy / Speer, Tod W.  

Público ISBD Ningún comentario para este título. Título : Targeted Radionuclide Therapy Tipo de documento: documento electrónico Autores: Speer, Tod W. Editorial: Philadelphia [USA] : Wolters Kluwer Health Fecha de publicación: 2011 Número de páginas: 1 online resource (561 pages) : Il.: illustrations (some color) ISBN/ISSN/DL: 978-1-4511-5326-2 Palabras clave:   Cancer  Radioimmunotherapy. Clasificación: 616.99/40642 Resumen: "Radioimmunotherapy, also known as systemic targeted radiation therapy, uses antibodies, antibody fragments, or compounds as carriers to guide radiation to the targets. It is a topic rapidly increasing in importance and success in treatment of cancer patients. This book represents a comprehensive amalgamation of the radiation physics, chemistry, radiobiology, tumor models, and clinical data for targeted radionuclide therapy. It outlines the current challenges and provides a glimpse at future directions. With significant advances in cell biology and molecular engineering, many targeting constructs are now available that will safely deliver these highly cytotoxic radionuclides in a targeted fashion"--Provided by publisher. Nota de contenido: bla part I. Immunology and targeting constructs -- part II. The science of targeted radionuclide therapy -- part III. Tumor microenvironment and delivery strategies -- part IV. Unconjugated therapy -- part V. Conjugated therapy. Enlace de acceso : https://elibro-net.biblioproxy.umanizales.edu.co/es/lc/umanizales/titulos/169520 Targeted Radionuclide Therapy [documento electrónico] / Speer, Tod W. . - Philadelphia [USA] : Wolters Kluwer Health, 2011 . - 1 online resource (561 pages) : : illustrations (some color). ISBN : 978-1-4511-5326-2 Palabras clave:   Cancer  Radioimmunotherapy. Clasificación: 616.99/40642 Resumen: "Radioimmunotherapy, also known as systemic targeted radiation therapy, uses antibodies, antibody fragments, or compounds as carriers to guide radiation to the targets. It is a topic rapidly increasing in importance and success in treatment of cancer patients. This book represents a comprehensive amalgamation of the radiation physics, chemistry, radiobiology, tumor models, and clinical data for targeted radionuclide therapy. It outlines the current challenges and provides a glimpse at future directions. With significant advances in cell biology and molecular engineering, many targeting constructs are now available that will safely deliver these highly cytotoxic radionuclides in a targeted fashion"--Provided by publisher. Nota de contenido: bla part I. Immunology and targeting constructs -- part II. The science of targeted radionuclide therapy -- part III. Tumor microenvironment and delivery strategies -- part IV. Unconjugated therapy -- part V. Conjugated therapy. Enlace de acceso : https://elibro-net.biblioproxy.umanizales.edu.co/es/lc/umanizales/titulos/169520

---

1 (1 - 1 / 1) Ver por página : 25 50 100 200